Literature DB >> 26517534

New Genetic Forms of Childhood-Onset Primary Osteoporosis.

Anders J Kämpe1, Riikka E Mäkitie, Outi Mäkitie.   

Abstract

Recent developments in genetic technology have given us the opportunity to look at diseases in a new and more detailed way. This Mini Review discusses monogenetic forms of childhood-onset primary osteoporosis, with the main focus on osteoporosis caused by mutations in WNT1 and PLS3, two of the most recently discovered genes underlying early-onset osteoporosis. The importance of WNT1 in the accrual and maintenance of bone mass through activation of canonical WNT signaling was recognized in 2013. WNT1 was shown to be a key ligand for the WNT-signaling pathway, which is of major importance in the regulation of bone formation. More recently, mutations in PLS3, located on the X chromosome, were shown to be the cause of X-linked childhood-onset primary osteoporosis affecting mainly males. The function of PLS3 in bone metabolism is still not completely understood, but it has been speculated to have an important role in mechanosensing by osteocytes and in matrix mineralization. In this new era of genetics, our knowledge on genetic causes of childhood-onset osteoporosis expands constantly. These discoveries bring new possibilities, but also new challenges. Guidelines are needed to implement this new genetic knowledge to clinical patient care and to guide genetic investigations in affected families.
© 2015 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26517534     DOI: 10.1159/000439566

Source DB:  PubMed          Journal:  Horm Res Paediatr        ISSN: 1663-2818            Impact factor:   2.852


  13 in total

1.  A novel frameshift deletion in PLS3 causing severe primary osteoporosis.

Authors:  Alice Costantini; Panagiotis Ν Krallis; Anders Kämpe; Emmanouil M Karavitakis; Fulya Taylan; Outi Mäkitie; Artemis Doulgeraki
Journal:  J Hum Genet       Date:  2018-06-08       Impact factor: 3.172

2.  Osteocyte Protein Expression Is Altered in Low-Turnover Osteoporosis Caused by Mutations in WNT1 and PLS3.

Authors:  Katherine Wesseling-Perry; Riikka E Mäkitie; Ville-Valtteri Välimäki; Tero Laine; Christine M Laine; Matti J Välimäki; Renata C Pereira; Outi Mäkitie
Journal:  J Clin Endocrinol Metab       Date:  2017-07-01       Impact factor: 5.958

Review 3.  Drug Treatment of Low Bone Mass and Other Bone Conditions in Pediatric Patients.

Authors:  Stefania Costi; Teresa Giani; Francesco Orsini; Rolando Cimaz
Journal:  Paediatr Drugs       Date:  2022-01-11       Impact factor: 3.022

4.  Heterozygous WNT1 variant causing a variable bone phenotype.

Authors:  Shatha Alhamdi; Yi-Chien Lee; Shimul Chowdhury; Peter H Byers; Michael Gottschalk; Ryan J Taft; Kyu Sang Joeng; Brendan H Lee; Lynne M Bird
Journal:  Am J Med Genet A       Date:  2018-09-24       Impact factor: 2.802

Review 5.  Plastin 3 in health and disease: a matter of balance.

Authors:  Lisa Wolff; Eike A Strathmann; Ilka Müller; Daniela Mählich; Charlotte Veltman; Anja Niehoff; Brunhilde Wirth
Journal:  Cell Mol Life Sci       Date:  2021-05-23       Impact factor: 9.261

6.  PLS3 sequencing in childhood-onset primary osteoporosis identifies two novel disease-causing variants.

Authors:  A J Kämpe; A Costantini; R E Mäkitie; N Jäntti; H Valta; M Mäyränpää; H Kröger; M Pekkinen; F Taylan; H Jiao; O Mäkitie
Journal:  Osteoporos Int       Date:  2017-07-26       Impact factor: 4.507

Review 7.  New Insights Into Monogenic Causes of Osteoporosis.

Authors:  Riikka E Mäkitie; Alice Costantini; Anders Kämpe; Jessica J Alm; Outi Mäkitie
Journal:  Front Endocrinol (Lausanne)       Date:  2019-02-25       Impact factor: 5.555

8.  Diagnostic yield of bone fragility gene panel sequencing in children and young adults referred for idiopathic primary osteoporosis at a single regional reference centre.

Authors:  Coline Rouleau; Margaux Malorie; Corinne Collet; Valérie Porquet-Bordes; Isabelle Gennero; Sanaa Eddiry; Michel Laroche; Jean Pierre Salles; Guillaume Couture; Thomas Edouard
Journal:  Bone Rep       Date:  2022-02-23

Review 9.  The Osteocyte as the New Discovery of Therapeutic Options in Rare Bone Diseases.

Authors:  Janak L Pathak; Nathalie Bravenboer; Jenneke Klein-Nulend
Journal:  Front Endocrinol (Lausanne)       Date:  2020-07-08       Impact factor: 5.555

Review 10.  The Polygenic and Monogenic Basis of Paediatric Fractures.

Authors:  S Ghatan; A Costantini; R Li; C De Bruin; N M Appelman-Dijkstra; E M Winter; L Oei; Carolina Medina-Gomez
Journal:  Curr Osteoporos Rep       Date:  2021-05-04       Impact factor: 5.096

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.